New Strong Sell Stocks for March 7th

Zacks Equity Research Published on March 07, 2017

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

Ambarella, Inc. (AMBA - Free Report) develops video compression and image processing semiconductors. The Zacks Consensus Estimate for its current year earnings has been revised 61.6% downward over the last 30 days.

Consolidated-Tomoka Land Co. (CTO - Free Report) is primarily engaged in the real estate industry. The Zacks Consensus Estimate for its current year earnings has been revised 49.7% downward over the last 30 days.

GCP Applied Technologies Inc. offers specialty construction chemicals and building materials as well as packaging technologies. The Zacks Consensus Estimate for its current year earnings has been revised 3.6% downward over the last 30 days.

Genesis Healthcare, Inc. (GEN - Free Report) provides long-term care, assisted/senior living and rehabilitation therapy. The Zacks Consensus Estimate for its current year earnings has been revised 60.7% downward over the last 30 days.

Ligand Pharmaceuticals Incorporated (LGND - Free Report) discovers, develops and markets new drugs globally. The Zacks Consensus Estimate for its current year earnings has been revised 46.8% downward over the last 30 days.

View the entire Zacks Rank #5 List.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.